1 documents found
Information × Registration Number 0213U000013, 0112U002757 , R & D reports Title Development of technique of obtaining, working off the prototype and pre-clinical testing of generic drug "Letrozole". Section 2. Pre-clinical study of generic drug "Letrozole". popup.stage_title Head Shlyakhovenko Volodymyr Oleksiyovych, Registration Date 09-01-2013 Organization R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology popup.description2 A study of common acute and chronic toxicity, anti-estrogenic activity and antitumor action of substance Letrozole synthesized in the Institute of Physical Organic Chemistry and manuscript. LM Litvinenko National Academy of Sciences of Ukraine, in comparison with officinal drug Femara firm Novartis. Findings indicate coincidence basic toxicological and pharmacological characteristics of the active substance and drug Letrozole Femara comparison. Product Description popup.authors Вербиненко А.В. Міліневська В.О. Малашко Л.І. Шляховенко В.О. popup.nrat_date 2020-04-02 Close
R & D report
Development of technique of obtaining, working off the prototype and pre-clinical testing of generic drug "Letrozole". Section 2. Pre-clinical study of generic drug "Letrozole".
Head: Shlyakhovenko Volodymyr Oleksiyovych. Development of technique of obtaining, working off the prototype and pre-clinical testing of generic drug "Letrozole". Section 2. Pre-clinical study of generic drug "Letrozole".. (popup.stage: ). R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology. № 0213U000013
1 documents found

Updated: 2026-03-27


Роздрукувати цю сторінку